パリビズマベは,子供の喘息発症を予防する要因ですか? メタナリシスによる体系的レビュー
Mariana Bueno Manini1, Natali Caroline da Silva1, Rafaela Agra de Castro2
1Child and Adolescent Health Postgraduate Program, State University of Campinas, Campinas, São Paulo, Brazil.
Pediatric pulmonology
|August 22, 2025
まとめ
パリビズマブによる予防は,心疾患のない早産児の喘息を予防しません. この薬は主に重度の呼吸器シンシチアルウイルス (RSV) 感染症を軽減しますが,小児性喘息の発症を軽減しません.
科学分野:
- 小児肺科
- 新生児科
- 臨床免疫学
背景:
- 胎児は慢性呼吸器疾患やRSVのような重症感染症のリスクが高くなります
- パリビズマブは高リスクの乳児のRSVの重症性を軽減することが知られているが,喘息の発症に対する効果は十分に確立されていない.
研究 の 目的:
- 既存の文献を体系的にレビューし,メタ分析する.
- パリビズマブによる予防が,早産児 (先天性心疾患のない) を喘息発症から守るかどうかを判断する.
主な方法:
- 14件の研究の体系的レビューとメタ解析.
- 9232人がパリビズマブを投与した.
- サブグループと感受性分析は,強度と特定の集団を評価するために行われました.
主要な成果:
- パリビズマブを投与された患者と対照群の間で喘息の発症の有意な差は認められなかった (OR 0. 84, p=0. 1968).
- アトピー経歴のサブグループ分析では,喘息のリスクが有意に低下していないことが示された.
- パリビズマブ治療を受けた乳児はより若い年齢で診断されたが,妊娠年齢の違いは有意ではなかった.
結論:
- パリビズマブによる予防は,先天性心疾患のない早産児の喘息リスクを下げない.
- パリビズマブの確立された利点は,重度のRSV感染を予防することであり,喘息の発症を予防することではない.
関連する概念動画
Asthma: Pathogenesis and Management
581
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
581
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Leukotriene Modifiers
463
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
463
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K


